Morgan Stanley Singular Genomics Systems, Inc. Transaction History

Morgan Stanley

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 17, 2024	BUY	$0.4 - $0.61 $3,484 - $5,314	8,712 New	8,712 $4,000
Q1 2024 Aug 16, 2024	SELL	$0.4 - $0.61 $8 - $12	-21 Reduced 0.24%	8,712 $4,000
Q1 2024 May 15, 2024	SELL	$0.4 - $0.61 $8 - $12	-21 Reduced 0.24%	8,712 $4,000
Q4 2023 Aug 16, 2024	BUY	$0.33 - $0.58 $2,881 - $5,065	8,733 New	8,733 $4,000
Q4 2023 Feb 13, 2024	SELL	$0.33 - $0.58 $1,692 - $2,974	-5,129 Reduced 37.0%	8,733 $4,000
Q3 2023 Nov 15, 2023	SELL	$0.37 - $0.99 $19,047 - $50,965	-51,480 Reduced 78.79%	13,862 $5,000
Q2 2023 Aug 14, 2023	SELL	$0.78 - $1.28 $15,275 - $25,067	-19,584 Reduced 23.06%	65,342 $54,000
Q1 2023 May 15, 2023	SELL	$1.1 - $2.95 $26,412 - $70,832	-24,011 Reduced 22.04%	84,926 $102,000
Q4 2022 Feb 14, 2023	BUY	$1.82 - $2.71 $12,048 - $17,940	6,620 Added 6.47%	108,937 $218,000
Q3 2022 Nov 14, 2022	BUY	$2.5 - $4.73 $49,470 - $93,597	19,788 Added 23.98%	102,317 $256,000
Q2 2022 Oct 27, 2022	BUY	$2.86 - $6.44 $88,577 - $199,453	30,971 Added 60.07%	82,529 $315,000
Q2 2022 Aug 15, 2022	BUY	$2.86 - $6.44 $88,577 - $199,453	30,971 Added 60.07%	82,529 $315,000
Q1 2022 Oct 27, 2022	SELL	$5.94 - $12.09 $183,967 - $374,439	-30,971 Reduced 37.53%	51,558 $326,000
Q1 2022 May 13, 2022	BUY	$5.94 - $12.09 $208,868 - $425,120	35,163 Added 214.47%	51,558 $326,000
Q4 2021 Feb 14, 2022	BUY	$10.45 - $16.9 $113,089 - $182,891	10,822 Added 194.19%	16,395 $189,000
Q3 2021 Nov 15, 2021	BUY	$10.9 - $27.63 $60,745 - $153,981	5,573 New	5,573 $62,000

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.52B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.